Is presurgical treatment with somatostatin analogs necessary in acromegalic patients?

Journal of Endocrinological Investigation

Volumn 22, Issue 11, 1999, Pages 871-873

  Losa, Marco ^a,b   Mortini, P ^a   Giovanell, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; ANTIBIOTIC AGENT; GROWTH HORMONE; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADENOMA; BLEEDING; BLOOD TRANSFUSION; CEREBROSPINAL FLUID DRAINAGE; HUMAN; LIQUORRHEA; LUNG INFECTION; NOTE; PEROPERATIVE COMPLICATION; PREOPERATIVE TREATMENT;

EID: 0033376774     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343662     Document Type: Note

References (11)

1. Giovanelli M., Losa M., Mortini P. Acromegaly: surgical results and prognosis. In: Landolt A.M., Vance M.L., Reilly P.L. (Eds.), Pituitary adenomas. Churchill Livingstone, Edinburgh, 1996, pp. 333-351.
2. Ezzat S., Snyder P.J., Young W.F., Boyajy L.D., Newman C. Klibanski A., Molitch M.E., Boyd A.E., Sheeler L., Cook D.M., Malarkey W.B., Jackson I., Vance M.L., Thorner M.O., Barkan A., Frohman L.A., Melmed S. Octreotide treatment of acromegaly: a randomized, multicenter study. Ann. Intern. Med. 1992, 117: 711-718.
3. Spinas G.A., Zapf J., Landolt A.M., Stuckmann G., Froesch E.R. Pre-operative treatment of 5 acromegalics with a somatostatin analogue: endocrine and clinical observations. Acta Endocrinol. (Copenh.) 1987, 114: 249-256.
4. th October 1991). Advances in the medical and surgical treatment of pituitary adenomas: The role of long-acting somatostatin analogs. J. Endocrinol. Invest. 1993, 16: 449-460.
5. Barkan A.L., Lloyd R.V., Chandler W.F., Hatfield M.K., Gebarski S., Kelch R.P., Beitins I.Z. Preoperative treatment of acromegaly with long-acting somatostatin analog SMS 201-995: Shrinkage of invasive pituitary macroadenomas and improved surgical remission rate. J. Clin. Endocrinol. Metab. 1988 67: 1040-1048.
6. Plöckinger U., Reichel M., Fett U., Saeger W., Quabbe H.-J. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effects on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy. J. Clin. Endocrinol. Metab. 1994, 79: 1416-1423.
7. Lucas-Morante T., Garcia-Uria J., Estrada J., Saucedo G., Cabello A., Alcañiz J., Barceló B. Treatment of invasive growth hormone pituitary adenomas with long-acting somatostatin analog SMS 201-995 before transsphenoidal surgery. J. Neurosurg. 1994, 81: 10-14.
8. Stevenaert A., Beckers A. Presurgical octreotide treatment in acromegaly. Metabolism1996, 45: 72-74.
9. Colao A., Ferone D., Cappabianca P., del Basso De Caro M.L., Marzullo P., Monticelli A., Alfieri A., Merola B., Calì A., de Divitiis E., Lombardi G. Effect of octreotide pretreatment on surgical outcome in acromegaly. J. Clin. Endocrinol. Metab. 1997, 82: 3308-3314.
10. Merola B., Cittadini A., Colao A., Ferone D., Fazio S., Sabatini D., Biondi B., Saccà L., Lombardi G. Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly. J. Clin. Endocrinol. Metab. 1993, 77: 790-793.
11. Lamberts S.W.J., van der Lely A.-J., de Herder W.W., Hofland L.J. Octreotide. N. Engl. J. Med. 1996, 334: 246-254.